New combo attack on tough cancers that resist other treatments
NCT ID NCT03259867
First seen Apr 18, 2026 · Last updated Apr 22, 2026 · Updated 1 time
Summary
This study is testing a two-step treatment for people with advanced liver cancer or stomach cancer that has spread to the liver and has stopped responding to standard therapies. First, doctors will deliver a cancer-fighting drug directly into the liver tumor's blood supply. Then, patients will receive an immunotherapy drug designed to help the body's immune system fight the cancer. The goal is to see if this combination can shrink tumors and control the disease in patients who have few other options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Email: •••••@•••••
-
University of California, Irvine
RECRUITINGOrange, California, 92868, United States
Contact Email: •••••@•••••
Contact
Contact
-
University of Oklahoma Health Science Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.